Journals / Harran Üniversitesi Veteriner Fakültesi Dergisi / 2021 / Cilt: 10 - Sayı: 1

Effect of Coenzyme Q10 on Plasma Parameters in Hypothyroıd Rats

Hipotiroidili Ratlarda Koenzim Q10'un Plazma Parametreleri Üzerine Etkisi

Pages
66–72
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was observed in the research that hypothyroidism administration (group H) decreased plasma glucoseand triglyceride values (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:This research was conducted to determine the effect of Coenzyme Q10 (CoQ10) on blood glucose, total protein,triglyceride, and total cholesterol levels in rats for that experimental hypothyroidism was induced.
📊
Key Findings & Data:A total of 32 healthyadult male Wistar Albino rats were used as a material in the research.
💡
Conclusion & Impact:It was observed in the research that hypothyroidism administration (group H) decreased plasma glucoseand triglyceride values (p
🔬Design:Lab & Field Experiment
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

This research was conducted to determine the effect of Coenzyme Q10 (CoQ10) on blood glucose, total protein,triglyceride, and total cholesterol levels in rats for that experimental hypothyroidism was induced. A total of 32 healthyadult male Wistar Albino rats were used as a material in the research. After the adaptation period of animals for ten days,the main research period was conducted for a total of three weeks. The rats housed as four rats in each cage during theresearch were divided into four experimental groups as control (K), CoQ10 (C), Hypothyroid (H), and CoQ10+Hypothyroid(CH). CoQ10 was administered intraperitoneally every day to the group C animals. In addition, propylthiouracil (PTU) wasadded daily to the water of rats in group H to induce experimental hypothyroidism. Both CoQ10 and PTU administrationwas performed on the animals in the group HC. At the end of the trial period, blood was drawn from the hearts of rats in allgroups. Glucose, total protein, triglyceride, and total cholesterol levels were determined in plasma samples obtained fromblood samples. It was observed in the research that hypothyroidism administration (group H) decreased plasma glucoseand triglyceride values (p

Özet

Deneysel olarak hipotiroidizm oluşturulmuş ratlarda Koenzim Q10 (KoQ10)’un kan glikoz, total protein, trigliserit ve total kolesterol düzeyleri üzerindeki etkisinin belirlenmesi amaçlandı. Araştırmada materyal olarak sağlıklı toplam 32 adet yetişkin erkek Wistar Albino ırkı rattan yararlanıldı. Hayvanların10 günlük adaptasyon süresini takiben esas araştırma dönemi toplam 3 hafta sürdürüldü. Çalışma süresince her kafeste 4 rat olacak şekilde barındırılan ratlar kontrol (K), KoQ10 (C), Hipotiroid (H) ve KoQ10+ Hipotiroid (CH) olmak üzere 4 deneme grubuna ayrıldı. C grubu hayvanlara her gün intraperitoneal olarak KoQ10 uygulandı. Deneysel hipotiroidizm oluşturmak amacıyla, H grubundaki ratların sularına günlük propiltiyourasil (PTU) ilave edildi. HC grubundaki hayvanlara ise hem KoQ10, hem de PTU uygulaması yapıldı. Deneme sonunda gruplardaki deneklerden genel anestezi altında kardiak punksiyon ile yeterli oranda kan alındı ve plazmaları elde edildi. Elde edilen plazma örneklerinden glikoz, total protein, trigliserit ve total kolesterol düzeyleri belirlendi. Araştırmada, hipotiroidizm oluşturulmasının, kontrol grubu ile kıyaslandığında plazma glikoz ve trigliserit değerlerini düşürdüğü (p

🔖

Cite This Article

KOCA, O., HATİPOĞLU, D., İNAN, A. O., DURGUN, Z. (2022). Effect of Coenzyme Q10 on Plasma Parameters in Hypothyroıd Rats. Harran Üniversitesi Veteriner Fakültesi Dergisi, Cilt: 10 - Sayı: 1, 66–72. https://ajindex.com/articles/534157

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Abdi S, Montazeri V, Garjani A, Shayanfar A, Pirouzpanah S, 2020: Coenzyme Q10 in association with metabolism-related AMPK/PFKFB3 and angiogenic VEGF/VEGFR2 genes in breast cancer patients. Mol Biol Rep; 47(4): 2459-2473.
  2. Acosta MJ, Fonseca LV, Desbats MA, Cerqua C, Zordan R, Trevisson E, Salviati L, 2016: Coenzyme Q biosynthesis in health and disease. BBA-Bioenergetics; 1857(8): 1079-1085.
  3. Alahmar AT, Sengupta P, 2020: Impact of Coenzyme Q10 and Selenium on Seminal Fluid Parameters and Antioxidant Status in Men with Idiopathic Infertility. Biol Trace Elem Res; 1-7. Alcázar-Fabra M, Navas P, Brea-Calvo G, 2016: Coenzyme Q biosynthesis and its role in the respiratory chain structure. BBA-Bioenergetics; 1857(8): 1073-1078.
  4. Beigneux AP, Allan CM, Sandoval NP, Cho GW, Heizer PJ, Jung RS, Stanhope KL, Havel PJ, Birrane G, Meiyappan M, 2019: Lipoprotein lipase is active as a monomer. PNAS-USA; 116(13): 6319-6328.
  5. Belardinelli R, Muçaj A, Lacalaprice F, Solenghi M, Seddaiu G, Principi F, Tiano L, Littarru GP, 2006: Coenzyme Q10 and exercise training in chronic heart failure. Eur Heart J; 27(22): 2675-2681.
  6. Bhagavan HN, Chopra RK, 2006: Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic. Res.; 40(5): 445-453.
  7. Castelo-Branco C, Steinvarcel F, Osorio A, Ros C, Balasch J, 2010: Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism. Gynecol Endocrinol; 26(10): 736-742.
  8. Comte B, Vidal H, Laville M, Riou J-P, 1990: Influence of thyroid hormones on gluconeogenesis from glycerol in rat hepatocytes: a dose-response study. Metab. Clin. Exp; 39(3): 259-263.
  9. Cooper D, Greenspan F, Ladenson P, 2007: Hyperthyroidism and Thyrotoxicosis. Greenspan’s basic and clinical endocrinology; 8th edition: 248-252.
  10. Diekman T, Demacker PN, Kastelein JJ, Stalenhoef AF, Wiersinga WM, 1998: Increased oxidizability of low-density lipoproteins in hypothyroidism. J. Clin. Endocrinol. Metab.; 83(5): 1752-1755.
  11. Dludla PV, Nyambuya TM, Orlando P, Silvestri S, Mxinwa V, Mokgalaboni K, Nkambule BB, Louw J, Muller CJ, Tiano L, 2020: The impact of coenzyme Q10 on metabolic and cardiovascular disease profiles in diabetic patients: A systematic review and meta‐analysis of randomized controlled trials. Endocrinol Diabetes Metab; 3(2): e00118. Duntas LH, Orgiazzi J, Brabant G, 2011: The interface between thyroid and diabetes mellitus. Clinical Endocrinology; 75(1): 1-9.
  12. Hayase K, Yonekawa G, Yokogoshi H, Yoshida A, 1991: Triiodothyronine admi